Back

Impact of left atrial appendage closure on events after severe bleeding in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Outcomes and strategies in left atrial appendage closure Left Atrial Appendage (LAA) Closure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Martin Ruiz Ortiz

Reina Sofia University Hospital, Cordoba (Spain)

4 More presentations in this session

Presentation thumbnail
Left atrial appendage closure in patients with cardioembolic stroke despite oral anticoagulant therapy: a multicenter case-control study
Doctor L. De Luca (Milan, IT)
Abstract Slides Video
Presentation thumbnail
An observational analysis of device-related thrombus in patients with atrial fibrillation across different generations of Watchman devices
Doctor K. Pant (New York City, US)
Abstract Slides Video
Presentation thumbnail
Antithrombotic strategies and DOAC dosing following left atrial appendage occlusion: a network meta-analysis
Doctor A. Samaras (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Discontinuation of antithrombotic management following left atrial appendage occlusion in high bleeding risk patients
Doctor S. Wong (Brighton, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Outcomes and strategies in left atrial appendage closure
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Outcomes and strategies in left atrial appendage closure
thumbnail
Congress Presentation
Impact of left atrial appendage closure on events after severe gastrointestinal bleeding in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry.
thumbnail
Congress Presentation
Real world data on left atrial appendage closure after severe bleeding in anticoagulated patients with atrial fibrillation: frequency and associated factors.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources